Cannabis, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back

被引:98
作者
Almogi-Hazan, Osnat [1 ]
Or, Reuven [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Ctr, Lab Immunotherapy & Bone Marrow Transplantat, Fac Med, IL-91120 Jerusalem, Israel
关键词
Cannabis; cannabinoid; immune; inflammation; infectious diseases; virus; bacteria; cancer; autoimmune; transplantation; VERSUS-HOST-DISEASE; MULTIPLE-SCLEROSIS; CB2; RECEPTOR; T-CELLS; HEMATOPOIETIC STEM; MEDICAL CANNABIS; B-CELLS; SATIVA; DELTA-9-TETRAHYDROCANNABINOL; ACTIVATION;
D O I
10.3390/ijms21124448
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TheCannabisplant contains numerous components, including cannabinoids and other active molecules. The phyto-cannabinoid activity is mediated by the endocannabinoid system. Cannabinoids affect the nervous system and play significant roles in the regulation of the immune system. WhileCannabisis not yet registered as a drug, the potential of cannabinoid-based medicines for the treatment of various conditions has led many countries to authorize their clinical use. However, the data from basic and medical research dedicated to medicalCannabisis currently limited. A variety of pathological conditions involve dysregulation of the immune system. For example, in cancer, immune surveillance and cancer immuno-editing result in immune tolerance. On the other hand, in autoimmune diseases increased immune activity causes tissue damage. Immuno-modulating therapies can regulate the immune system and therefore the immune-regulatory properties of cannabinoids, suggest their use in the therapy of immune related disorders. In this contemporary review, we discuss the roles of the endocannabinoid system in immunity and explore the emerging data about the effects of cannabinoids on the immune response in different pathologies. In addition, we discuss the complexities of using cannabinoid-based treatments in each of these conditions.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 139 条
[1]   *Endocannabinoid system acts as a regulator of immune homeostasis in the gut [J].
Acharya, Nandini ;
Penukonda, Sasi ;
Shcheglova, Tatiana ;
Hagymasi, Adam T. ;
Basu, Sreyashi ;
Srivastava, Pramod K. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (19) :5005-5010
[2]   Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression [J].
Adhikary, Sabina ;
Kocieda, Virginia P. ;
Yen, Jui-Hung ;
Tuma, Ronald F. ;
Ganea, Doina .
BLOOD, 2012, 120 (18) :3741-3749
[3]   Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies [J].
Akguen, Katja ;
Essner, Ute ;
Seydel, Cordula ;
Ziemssen, Tjalf .
JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2019, 11
[4]   Oral Ingestion of Cannabis sativa: Risks, Benefits, and Effects on Malaria-Infected Hosts [J].
Akinola, Olugbenga ;
Ogbeche, Elizabeth O. ;
Olumoh-Abdul, Hidayah A. ;
Alli-Oluwafuyi, Abdulmusawwir O. ;
Oyewole, Aboyeji L. ;
Amin, Abdulbasit ;
AbdulMajeed, Wahab Imam ;
Olajide, Olayemi Joseph ;
Nafiu, Abdurrazaq B. ;
Njan, Anoka A. ;
Olorundare, Olufunke E. ;
Gbotosho, Grace O. .
CANNABIS AND CANNABINOID RESEARCH, 2018, 3 (01) :219-227
[5]   Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation [J].
Alhouayek, Mireille ;
Lambert, Didier M. ;
Delzenne, Nathalie M. ;
Cani, Patrice D. ;
Muccioli, Giulio G. .
FASEB JOURNAL, 2011, 25 (08) :2711-2721
[6]   Cannabis, Cannabinoids, and the Endocannabinoid SystemIs there Therapeutic Potential for Inflammatory Bowel Disease? [J].
Ambrose, Tim ;
Simmons, Alison .
JOURNAL OF CROHNS & COLITIS, 2019, 13 (04) :525-535
[7]   Antibacterial cannabinoids from Cannabis sativa:: A structure-activity study [J].
Appendino, Giovanni ;
Gibbons, Simon ;
Giana, Anna ;
Pagani, Alberto ;
Grassi, Gianpaolo ;
Stavri, Michael ;
Smith, Eileen ;
Rahman, Mukhlesur .
JOURNAL OF NATURAL PRODUCTS, 2008, 71 (08) :1427-1430
[8]   Lower circulating endocannabinoid levels in children with autism spectrum disorder [J].
Aran, Adi ;
Eylon, Maya ;
Harel, Moria ;
Polianski, Lola ;
Nemirovski, Alina ;
Tepper, Sigal ;
Schnapp, Aviad ;
Cassuto, Hanoch ;
Wattad, Nadia ;
Tam, Joseph .
MOLECULAR AUTISM, 2019, 10 (1)
[9]  
Baram Liran, 2019, Oncotarget, V10, P4091, DOI 10.18632/oncotarget.26983
[10]  
Batugedara HM, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00441-18, 10.1128/iai.00441-18]